Inventor · disambiguated record
Paul J. Fielder
Also filed as: FIELDER PAUL J
6 granted patents·7 pending applications·65 citations·filing 2000–2013
77Inventor score
Top patents by PatentIndex Score
13 records- 0191US6403764B1Insulin-like growth factor-1 protein variantsGENENTECH INC·Filed 2000·Granted Jun 11, 2002·64 cites·3 claims
- 0272US7423017B2Method for treating cartilage disordersGENENTECH INC·Filed 2002·Granted Sep 9, 2008·1 cites·8 claims
- 0364US2013224193A1Methods and compositions for diagnostic use in cancer patientsGENENTECH INC·Filed 2013·Application pending·0 cites
- 0463US7947650B2Article of manufactureGENENTECH INC·Filed 2007·Granted May 24, 2011·0 cites·7 claims
- 0558US2010216115A1Methods and compositions for diagnostic use in cancer patientsGENENTECH INC·Filed 2009·Application pending·0 cites
- 0657US8110548B2Method for treating cartilage disordersCHEN YVONNE MAN-YEE·Filed 2007·Granted Feb 7, 2012·0 cites·13 claims
- 0756US2008095771A1Treatment MethodGENENTECH INC·Filed 2007·Application pending·0 cites
- 0855US2008299117A1Treatment MethodBARRON HAL V·Filed 2008·Application pending·0 cites
- 0954US2013224194A1Methods and compositions for diagnostic use in cancer patientsGENENTECH INC·Filed 2013·Application pending·0 cites
- 1051US2006188495A1Treatment methodGENENTECH INC·Filed 2006·Application pending·0 cites
- 1150US8097587B2IGF-I protein variants for treating IGFBP-1-related disordersDUBAQUIE YVES·Filed 2006·Granted Jan 17, 2012·0 cites·7 claims
- 1250US7105167B2Methods for treating clinical manifestations of GH/GF axis dysregulation by administration of an IGF-I variantGENENTECH INC·Filed 2001·Granted Sep 12, 2006·0 cites·17 claims
- 1350US2010021460A1Methods of Treating Autoimmune Diseases Using CD4 AntibodiesGENENTECH INC·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul J. Fielder files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →